🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12323+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12323 recruiting trials

Enrolling by InvitationNCT07316387

Neurobehavioral Development in Toddlers and Preschoolers in Relation to Prenatal Exposure of Mild Analgesics (NeuroToP - a COPANA Follow up)

🏥 Rigshospitalet, Denmark📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06657898

Complicated Pneumonia (CP) in Children in South-East Europe

🏥 Aleksandar Sovtic📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06527326

the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy

👨‍⚕️ Panpan Ye, doctor, 2 nd Affiliated Hospital, School of Medicine, Zhejiang University, China📍 1 site📅 Started May 2024View details ↗
Phase 2RecruitingNCT06302491

A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia

👨‍⚕️ Yusha Zhu, MD, PhD, Kind Pharmaceuticals LLC📍 5 sites📅 Started May 2024View details ↗
NARecruitingNCT06385405

Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment

👨‍⚕️ TianHong Zhang, Doctor, Shanghai Mental Health Center📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06465160

A Study to Evaluate the MNV-201 in Patients With Low Risk MDS

🏥 Minovia Therapeutics Ltd.📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06389305

CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

🏥 Beijing GoBroad Hospital📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06423131

Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT

👨‍⚕️ Jing Chen, PhD, Shanghai Children's Medical Center📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06396260

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

🏥 Aalborg University Hospital📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06639113

From Administration of Oral Medicines by Nurses to Controlled Self-administration: Impact on Safety of Administration During Hospitalisation

👨‍⚕️ Quentin HIVER, PH, Centre Hospitalier de Valenciennes📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06378437

A Study of GLB-001 in Patients With Myeloid Malignancies

👨‍⚕️ Gang Lu, Ph.D., Hangzhou GluBio Pharmaceutical Co., Ltd.📍 14 sites📅 Started May 2024View details ↗
EARLY_Phase 1RecruitingNCT06659653

Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.

🏥 Tan Jie📍 1 site📅 Started May 2024View details ↗
Phase 1, PHASE2RecruitingNCT06438809

Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis

🏥 Jiangsu Topcel-KH Pharmaceutical Co., Ltd.📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06445062

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

👨‍⚕️ Study Director, Revolution Medicines📍 20 sites📅 Started May 2024View details ↗
EARLY_Phase 1RecruitingNCT06458010

Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)

🏥 RenJi Hospital📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06907186

An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT04715191

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

👨‍⚕️ Andras Heczey, MD, Baylor College of Medicine📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06195891

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

👨‍⚕️ Amandeep Salhotra, City of Hope Medical Center📍 1 site📅 Started May 2024View details ↗
Phase 3RecruitingNCT06345729

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 212 sites📅 Started May 2024View details ↗
Phase 2RecruitingNCT05977673

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

👨‍⚕️ Pier Luigi Zinzani, MD, Istituto di Ematologia "L. e A. Seràgnoli", AOU Policlinico S.Orsola-Malpighi, Bologna📍 10 sites📅 Started May 2024View details ↗
← PreviousPage 291 of 617Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →